Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-α, IL-1β, and IL-1Ra genes

Journal of Rheumatology

Volumn 29, Issue 2, 2002, Pages 212-219

  Trifunovic Cvetkovic, Jasmina ^a   Wållberg Jonsson, Solveig ^a   Stegmayr, Birgitta ^a   Rantapää Dahlqvist, Solbritt ^a   Lefvert, Ann Kari ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Interleukin 1 receptor antagonist; Interleukin 1 ; Polymorphism; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SWEDEN;

ADULT; ALLELES; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036158534     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Heterogeneity of rheumatoid arthritis: From phenotypes to genotypes
2. Immunoprinting: Various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients
3. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism
4. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1 *04-bearing haplotypes in rheumatoid arthritis patients
5. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease?
6. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: Influence on disease outcome
7. IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes
8. MspI polymorphism in the human interleukin 6 (IL 6) gene
9. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro
10. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease
11. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
12. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritis
13. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis
14. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
15. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene
16. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis
17. Regulation of inflammatory vascular damage
18. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: Basic issues and clinical expectations
19. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis
20. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs
21. Role of cytokines in rheumatoid arthritis
22. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts
23. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: Localization in the pannus-hard tissue junction and inhibition by alendronate
24. Increased mortality in rheumatoid arthritis
25. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians
26. Cardiovascular mortality in women with rheumatoid arthritis
27. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden
28. Cytokine expression in advanced human atherosclerotic plaques: Dominance of proinflammatory (Th1) and macrophage-stimulating cytokines
29. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease
30. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis
31. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis
32. Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis
33. The significance of vascular inflammation in rheumatoid arthritis
34. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset
35. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: An 8 year followup study
36. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
37. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study
38. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: A nested case-control study
39. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist
40. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product
41. Map of the human MHC
42. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study
43. Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis
44. Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis
45. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
46. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha
47. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis
48. Turnout necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis
49. TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis
50. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis
51. A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis
52. Polymorphism at the TNF loci in rheumatoid arthritis
53. Polymorphisms in the 5′-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis
54. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated
55. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis
56. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
57. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
58. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
59. Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist
60. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation